HENRY CRABBE: Open Payments
NPI 1144282898 · NEW LONDON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$477 in 7 payments from 5 companies in 2025. Trend: 2023 $311 · 2024 $242 · 2025 $477
Food & beverage: $453Education: $24
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $142 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Alkermes, Inc. | 1 | $99 |
| Luye Pharma (USA) Ltd. | 1 | $99 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: FANAPT, Auvelity, LYBALVI, ERZOFRI EXTENDED-RELEASE, INGREZZA.
Industry payments across CT — which companies pay providers there.
